Impact on hospital policy: Yale experience

Area of Science:

• Nephrology
• Radiology
• Pharmacology

Background:

• Gadolinium-based contrast agents (GBCAs) are used in magnetic resonance imaging.
• Nephrogenic Systemic Fibrosis (NSF) is a serious condition linked to GBCAs in patients with impaired kidney function.
• Previous protocols may not have adequately screened or managed patients at risk for NSF.

Purpose of the Study:

• To implement and describe new hospital policies aimed at minimizing NSF risk.
• To outline strategies for safer GBCA administration in at-risk patient populations.
• To provide a rationale for revised clinical procedures regarding GBCA use.

Main Methods:

• Implementing patient screening for low estimated glomerular filtration rates (eGFR).
• Identifying and assessing risk factors for chronic kidney disease (CKD).
• Standardizing the selection of GBCA type and dosage.
• Developing and agreeing upon alternative imaging algorithms.
• Conducting multi-level medical community education on new protocols.

Main Results:

• Establishment of comprehensive screening protocols for patients undergoing MRI with GBCAs.
• Refined guidelines for GBCA administration, including dose and type selection.
• Development of alternative imaging strategies to reduce GBCA exposure.
• Increased awareness and education among healthcare professionals regarding NSF risks and prevention.

Conclusions:

• New hospital-wide policies effectively address the risk of NSF from GBCAs.
• Proactive patient screening and modified contrast agent management are crucial for patient safety.
• The implemented changes represent a significant advancement in the safe use of GBCAs in at-risk populations.